Skip to main content

Table 1 Characteristics of the patients enrolled (N = 77)

From: Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study

 

RT group (N = 39)

Propofol group (N = 38)

P value

Age (years)

70.4 ± 3.9

69.1 ± 4.0

0.185

Sex (male/female)

25/14

22/16

0.373

Height (cm)

164.3 ± 7.5

163.0 ± 8.1

0.459

Weight (kg)

62.3 ± 9.5

61.3 ± 11.1

0.678

BMI (kg/m2)

23.0 ± 3.0

23.0 ± 3.4

0.958

ASA classification (grade I/II)

7/32

7/31

0.595

Medical comorbidities

 Hypertension (N.)

16

16

0.554

 Diabetes mellitus (N.)

4

5

0.483

 CHD (N.)

5

4

0.483

 COPD (N.)

6

4

0.385

 History of surgery (N.)

21

17

0.284

  1. Data are expressed as the frequencies or means ± SDs, as appropriate
  2. BMI Body mass index, ASA American Society of Anaesthesiologists, CHD Coronary heart disease, COPD Chronic obstructive pulmonary disease